Pediatric Cancer Burden in Different Regions of India: Analysis of Published Data From 33 Population-Based Cancer

Atul Budukh1, Sonali Bagal2, Jarnail Singh Thakur3

  • 1Centre for Cancer Epidemiology (CCE), Tata Memorial Centre (TMC),Navi Mumbai, Maharashtra and Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, Maharashtra. Correspondence to: DrAtul Madhukar Budukh, Professor, Epidemiology Centre for Cancer Epidemiology,Tata Memorial Centre, Homi Bhabha National Institute, Maharashtra. budukham@tmc.gov.in.

Indian Pediatrics
|April 20, 2023
PubMed

Insights

Pediatric cancer accounts for 2% of all cancer cases in India. Incidence rates are higher in boys than girls, with northern India reporting the highest burden.

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Pediatric cancer represents a significant global health challenge, particularly in low and middle-income countries.
  • Understanding the burden and patterns of pediatric cancer is crucial for effective resource allocation and intervention strategies.
  • India, with its vast population, requires detailed epidemiological data on childhood cancers.

Purpose of the Study:

  • To determine the regional burden and patterns of pediatric cancer (ages 0-14 years) across India.
  • To analyze incidence rates based on available data from population-based cancer registries.
  • To identify geographic variations in pediatric cancer occurrence within India.

Main Methods:

  • Utilized published data from population-based cancer registries under the National Cancer Registry Programme and Tata Memorial Centre.
  • Categorized registries into six geographic regions for analysis.
  • Calculated age-specific and age-standardized incidence rates per million population, including 95% confidence intervals.

Main Results:

  • Pediatric cancers constitute 2% of all cancer cases in India.
  • The age-standardized incidence rate for boys was 95.1 per million, and for girls was 65.5 per million.
  • Northern India exhibited the highest pediatric cancer incidence rates, while northeastern India reported the lowest.

Conclusions:

  • The study highlights regional disparities in pediatric cancer incidence across India.
  • Accurate pediatric cancer burden assessment necessitates the establishment of dedicated pediatric cancer registries nationwide.
  • Further research and improved data collection are essential for targeted interventions and improved outcomes for childhood cancer in India.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
406
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
660
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K